Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Oct 30, 2015 12:02pm

124 Views

Post# 24243609

RE:RE:RE:Clinical experience and outcome of PDT in early lung cancer

As posted,

" if you think of the anatomy.. what best suits PDT
Lung, Bladder & Esophagus. Easily accessed
.... light can hit the lining of and into the structures."

Anyone here ever figure out why the Roger White requires the TLC-3200
(used to be the TLC-3000) to activate TLD-1433??
Photofrin, Laserpherin etc have all been activated via prior art
... this is not new science but he has not offerred any explanation to date
that I have heard.

P.s. This question is for anyone except bencro because I know you don't
have a clue and it will spare everyone here having to read thru your muddled,
off topic response.

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row